Nexalin Technology
NXL | NASDAQ
$1.56
+$0.08 (+5.41%)
At close: Nov 16, 2026, 4:00 PM ET
$1.54
-$0.02 (-1.28%)
After-hours:
Nov 16, 2026, 6:00 PM ET
+5.41%
(1D)Rating
32.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #722/1021 (Top 71%)
Key Statistics
Market Data
Market Cap $1.93M
1D Range
1.45 1.61
52W Range
1.40 32.70
Valuation (TTM)
PE -0.11
PB 7.33
EV/EBITDA -0.26
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -328.3%
SBC Adj. FCF Yield -440.5%
SBC Impact -34.2%
Margins
Gross Margin -101.3%
Operating Margin -3386.0%
FCF Margin -2283.9%
Growth (CAGR)
Revenue 3Y | 5Y 29.2% |
12.7%
Dil EPS 3Y | 5Y 14.8% |
-7.9%
FCF 3Y | 5Y -24.6% |
-25.1%
Returns
ROA -285.2%
ROE -445.5%
ROIC -629.9%
Financial Health
Net Debt
$159.67K
Current Ratio 0.69
Interest Coverage -177.93
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. ...
Sector Healthcare
Industry Medical - Devices
Employees 8
IPO Date Sep 16, 2022
Website www.nexalin.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$3.43
Miss -17.87%
YoY:
-2538.46% REV
$78.3K
Beat +4.40%
YoY:
+331.43%Next Earnings
Mar 24, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove NXL